Abaxis Inc (ABAX) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Abaxis Inc  (ABAX)
 

Abaxis Inc Growth Comparisons

Select each growth Category to receive further Information





ABAX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 16.7 % 14.62 % 8.23 % 8.09 %
Q / Q Revenue Growth (Q1 MRQ) 13.82 % -8.09 % -10.94 % -2.22 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 7.69 % 12.14 % 6.78 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 4.14 % 3.26 % 1.26 % 1.91 %
Revenue 5 Year Average Growth 5.64 % -0.27 % 8.78 % 9.24 %


ABAX's Growth Comparisons in IV. Quarter 2018




Abaxis Inc improved it's Revenue by 16.7% year on year in the fourth quarter 2018, and outpaced the 14.62% rise in the Laboratory Analytical Instruments industry, and 8.23% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Laboratory Analytical Instruments industry, helped to elevate overall market growth to 8.09%.

Top-line improved by 13.82% from the third quarter. Looking into annual sales rise of 5.64%, and S & P 500's average yearly sales growth is 9.24% over the five years, including only Businesses with the fourth quarter 2018 Results. Abaxis Inc grew less than the market.


Growth Rates of ABAX's Income in the fourth quarter 2018


ABAX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 29.51 % -46.89 % -13.04 %
Sequential Operating Income Change (Q1 MRQ) - -29.74 % 26.4 % -15.12 %
Y / Y Operating Income Growth (Q1 TTM) -94.09 % 20.76 % -28.04 % 5.79 %
Sequential Operating Income Growth (Q1 TTM) -93.01 % 5.39 % -13.9 % -2.24 %
Operating Income 5 Year Avg. Change -1.71 % 2.02 % 1.43 % 10.79 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 32.84 % 76.84 % -4.01 % 17.95 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 137.1 % - - 86.86 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -17.09 % -17.94 % -65.29 % 10.34 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 10.03 % 40.88 % -1.15 % 5.32 %
Income from Cont. Ops. 5 Year Avg. Change -0.21 % 6.56 % 7.65 % 8.01 %

ABAX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 25.91 % 75.46 % -1.45 % 19.37 %
Q / Q Net Income Growth (Q1 MRQ) 124.94 % - - 98.42 %
Y / Y Net Income Change (Q1 TTM) -18.5 % -13.23 % -69.44 % 7.4 %
Sequential Net Income Change (Q1 TTM) 7.92 % 36.76 % 1.04 % 7.35 %
Net Income 5 Year Avg. Growth -0.21 % 6.61 % 1.35 % 8.3 %

ABAX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 29.41 % 635.21 % -4.01 % 17.95 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 131.58 % - - 86.86 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -17.81 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 9.09 % - - 3.31 %
EPS from Cont. Ops. 5 Year Avg. Growth -3.31 % 4.13 % 7.65 % 8.01 %



ABAX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 30.3 % 629.5 % -1.45 % 8.01 %
Q / Q EPS Net Growth (Q1 MRQ) 138.89 % - - 98.42 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 57.61 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 9.26 % - - 2.95 %
EPS Net 5 Year Avg. Change -1 % 6.61 % 1.35 % 8.3 %



With 30.3% year on year EPS increase in the fourth quarter 2018, Abaxis Inc grew less than the 629.5% surge in the Laboratory Analytical Instruments industry, but beating the -1.45% decrease in the Healthcare sector. Comparing fourth quarter income per share growth, both Laboratory Analytical Instruments industry and Abaxis Inc outperformed 19.37% overall market increase.

The Company's sequential EPS growth rate was very impressive 138.89% from the third quarter. Average yearly income per share growth for Abaxis Inc is -1%, while S & P 500's average annual income per share growth is 8.3% over the five years, including only Businesses with the fourth quarter 2018 earnings results.

ABAX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -41.51 % 25.7 % 9.45 % 65.02 %
Sequential Free Cash Flow Change (Q1 MRQ) -54.66 % -25.42 % -40.87 % -20.28 %
Y / Y Free Cash Flow Change (Q1 TTM) -25.07 % 14.61 % 2.86 % 4.11 %
Sequential Free Cash Flow Change (Q1 TTM) -17.38 % 5.87 % 0.64 % 6.25 %
Free Cash Flow 5 Year Avg. Change 4.5 % 1.83 % 9.29 % 31.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - 115.03 % - 646.37 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - 611.75 % -13.46 % 551.36 %
Sequential Net Cash Flow Change (Q1 TTM) - 34.68 % 66.87 % 72.99 %
Net Cash Flow 5 Year Avg. Change - - 59.89 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -41.96 % 8.56 % -13.24 % 33.36 %
Sequential Capital Expenditures Change (Q1 MRQ) -18.6 % -9.37 % -44.64 % -18.8 %
Y / Y Capital Expenditures Change (Q1 TTM) -40.56 % 2.6 % 1.71 % 6.2 %
Sequential Capital Expenditures Change (Q1 TTM) -13.02 % 2.01 % -2.99 % 4.92 %
Capital Expenditures 5 Year Avg. Change - 9.2 % 8.3 % 9.42 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.